- Home
- NGEN vs INGN Comparison
NGEN vs INGN Comparison
Compare NGEN & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGEN | INGN |
|---|---|---|
| Founded | 2017 | 2001 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.5M | 177.1M |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | NGEN | INGN |
|---|---|---|
| Price | $1.86 | $5.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $18.00 | $11.25 |
| AVG Volume (30 Days) | ★ 375.0K | 233.6K |
| Earning Date | 04-02-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $348,668,000.00 |
| Revenue This Year | N/A | $8.03 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $1.58 | $5.34 |
| 52 Week High | $5.93 | $9.13 |
Technical Indicators
Market Signals| Indicator | NGEN | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 57.39 | 34.61 |
| Support Level | $1.59 | $5.48 |
| Resistance Level | $2.22 | $6.73 |
| Average True Range (ATR) | 0.09 | 0.24 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 95.35 | 5.88 |
Price Performance
Historical ComparisonAbout NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
About INGN Inogen Inc
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.